Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature

References

• MacDonald BK, Cockerell OC, Sander JW, . The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665–676.
   PubMed Web of Science ®Google Scholar
• Hoch W, McConville J, Helms S, . Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365–368.
   PubMed Web of Science ®Google Scholar
• van der Geld HW, Strauss AJ. Myasthenia gravis. Immunological relationship between striated muscle and thymus. Lancet 1966;1:57–60.
   PubMed Web of Science ®Google Scholar
• Gilhus NE, Aarli JA, Matre R. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies. Acta Neurol Scand 1983;68:328–336.
   PubMed Web of Science ®Google Scholar
• Atassi N, Amato AA. Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation. Muscle Nerve 2008;38:1074–1075.
   PubMed Web of Science ®Google Scholar
• Simon Z, Ress Z, Toldi J, . Rare association of Hodgkin lymphoma, Graves’ disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility? Int J Hematol 2009;89:523–528.
   PubMed Web of Science ®Google Scholar
• Gilhus NE, Aarli JA, Matre R. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies. Neurology 1984;34:246–249.
   PubMed Web of Science ®Google Scholar
• Cikes N, Momoi MY, Williams CL, . Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin Proc 1988;63:474–481.
   PubMed Web of Science ®Google Scholar
• Williams CL, Hay JE, Huiatt TW, . Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab Invest 1992;66:331–336.
   PubMed Web of Science ®Google Scholar
• Romi F, Skeie GO, Gilhus NE, . Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 2005;62:442–446.
   PubMed Web of Science ®Google Scholar
• Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann NY Acad Sci 1966;135:496–505.
   PubMed Web of Science ®Google Scholar
• Genkins G, Papatestas AE, Horowitz SH, . Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Am J Med 1975;58:517–524.
   PubMed Web of Science ®Google Scholar
• Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest 2006;116:2843–2854.
   PubMed Web of Science ®Google Scholar
• Skeie GO, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 2008;15:1029–1033.
   PubMed Web of Science ®Google Scholar
• Mackey JR, Desai S, Larratt L, . Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997;19:939–942.
   PubMed Web of Science ®Google Scholar
• Dowell JE, Moots PL, Stein RS. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma. Bone Marrow Transplant 1999;24:1359–1361.
   PubMed Web of Science ®Google Scholar
• Vogel JM, Kornfeld P, Forte FA, . Myasthenia gravis: association with chronic lymphocytic leukemia. NY State J Med 1977;77:2252–2256.
   PubMedGoogle Scholar
• Fujimaki K, Takasaki H, Koharazawa H, . Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia. Leuk Lymphoma 2005;46:1101–1102.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Waxman S. Myasthenia gravis, chronic lymphocytic leukemia, and autoimmune hemolytic anemia. A spectrum of thymic abnormalities? Arch Intern Med 1967;120:717–720.
   PubMed Web of Science ®Google Scholar
• Null JA, Livolsi VA, Glenn WW. Hodgkin's disease of the thymus (granulomatous thymoma) and myasthenia gravis: a unique association. Am J Clin Pathol 1977;67:521–525.
   PubMed Web of Science ®Google Scholar
• Tranchant C, Racamier E, Warter JM. Seronegative myasthenia gravis and familial Hodgkin's disease. Eur Neurol 1993;33:17–19.
   PubMed Web of Science ®Google Scholar
• Quilichini R, Fuentes P, Metge G, . [Myasthenic syndrome disclosing Hodgkin disease]. Rev Neurol (Paris) 1994;150:81–82.
   PubMed Web of Science ®Google Scholar
• Ferro MT, Riccardi T, Montanelli A, . Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease. J Neurol 2006;253:1241–1242.
   PubMed Web of Science ®Google Scholar
• Abrey LE. Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy. Neurology 1995;45:1019.
   PubMed Web of Science ®Google Scholar
• Mohri H, Harano H, Okubo T. Concomitant association of myasthenia gravis and pure red cell aplasia after chemotherapy for Hodgkin's disease. Am J Hematol 1997;54:343.
   PubMed Web of Science ®Google Scholar
• Liu KL, Herbrecht R, Tranchant C, . Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association. Nouv Rev Fr Hematol 1992;34:221–223.
   PubMedGoogle Scholar
• Bowen JD, Kidd P. Myasthenia gravis associated with T helper cell lymphoma. Neurology 1987;37:1405–1408.
   PubMed Web of Science ®Google Scholar
• Mortimer JE, Kidd P. Myasthenia gravis and lymphoblastic lymphoma antiacetylcholine receptor antibody as a tumor marker—a case report. Cancer Invest 1989;7:327–331.
   PubMed Web of Science ®Google Scholar
• Strauchen JA. Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis. Am J Surg Pathol 2001;25:411–415.
   PubMed Web of Science ®Google Scholar
• Uner AH, Abali H, Engin H, . Myasthenia gravis and lymphoblastic lymphoma involving the thymus: a rare association. Leuk Lymphoma 2001;42:527–531.
   PubMed Web of Science ®Google Scholar
• Bartoloni C, Scoppetta C, Flamini G, . Waldenstrom's macroglobulinemia and myasthenia gravis. J Clin Lab Immunol 1981;6:275–278.
   PubMedGoogle Scholar
• Lin YT, Kuo HC, Chang YT, . Myasthenia gravis and Waldenstrom's macroglobulinemia: a case report and review of the literature. Acta Neurol Scand 2001;104:246–248.
   PubMed Web of Science ®Google Scholar
• Davis S, Schumacher MJ. Myasthenia gravis and lymphoma. A clinical and immunological association. JAMA 1979;242:2096–2097.
   PubMed Web of Science ®Google Scholar
• Gajra A, Vajpayee N, Grethlein SJ. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. Am J Hematol 2004;77:196–197.
   PubMed Web of Science ®Google Scholar
• Takagi K, Yoshida A, Iwasaki H, . Anti-CD20 antibody (rituximab) therapy in a myasthenia gravis patient with follicular lymphoma. Ann Hematol 2005;84:548–550.
   PubMed Web of Science ®Google Scholar
• Manckoundia P, Martin-Pfitzenmeyer I, Pfitzenmeyer P. Myasthenia gravis associated with a B-cell, non-Hodgkin's lymphoma. Eur J Intern Med 2006;17:146.
   PubMed Web of Science ®Google Scholar
• Montes M, Tomasi TB Jr, Noehren TH, . Lymphoid interstitial pneumonia with monoclonal gammopathy. Am Rev Respir Dis 1968;98:277–280.
   PubMedGoogle Scholar
• Gabrielli GB, Codella O, Capra F, . Pulmonary mucosa-associated lymphoid tissue lymphoma and myasthenia gravis. A case report. Haematologica 1998;83:381–382.
   PubMed Web of Science ®Google Scholar
• Silberstein EB. Myasthenia gravis, haemolytic anaemia, and lymphoreticular malignancy. Br Med J 1970;3:445–446.
   PubMed Web of Science ®Google Scholar
• Levo Y, Kott E, Atsmon A. Association between myasthenia gravis and malignant lymphoma. Eur Neurol 1975;13:245–250.
   PubMed Web of Science ®Google Scholar
• Rowland LP, Osserman EF, Scharfman WB, . Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality. Am J Med 1969;46:599–605.
   PubMed Web of Science ®Google Scholar
• Faure A, Gattegno L, Modigliani E, . Antibodies against myoid thymic cells and striated muscle, and monoclonal gammapathy in myasthenia gravis. Biomedicine 1975;23:241–245.
   PubMedGoogle Scholar
• Somer H, Pirskanen R, Lefvert AK, . Myasthenia gravis and monoclonal IgG gammopathy. Neurology 1979;29:842–847.
   PubMed Web of Science ®Google Scholar
• Galli M, Landi G, Restelli DL, . Myasthenia gravis with a monoclonal gammopathy—report of a case. J Neurol Sci 1980;45:103–108.
   PubMed Web of Science ®Google Scholar
• Mottier D, Fine JM, Youinou P, . [Myasthenia gravis and asymptomatic monoclonal gammapathy. Detection of autoantibody activity of the monoclonal immunoglobulin]. Rev Fr Transfus Immunohematol 1981;24:571–577.
   Google Scholar
• Poloni M, Rocchelli B, Pinelli P, . Neuromuscular diseases associated with benign monoclonal gammopathy. Study of CSF and serum proteins by isoelectric focusing. Acta Neurol Scand 1982;65:154–159.
   PubMed Web of Science ®Google Scholar
• Soppi E, Eskola J, Roytta M, . Thymoma with immunodeficiency (Good's syndrome) associated with myasthenia gravis and benign IgG gammopathy. Arch Intern Med 1985;145:1704–1707.
   PubMed Web of Science ®Google Scholar
• Ahmed AR, Marchbank AJ, Nicholson AG, . Extramedullary plasmacytoma presenting with myasthenia gravis and mediastinal mass. Ann Thorac Surg 2000;70:1390[48]–1392.
   Web of Science ®Google Scholar
• Urbanska-Rys H, Robak E, Kordek R, . Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma. Leuk Lymphoma 2004;45:1913–1918.
   PubMed Web of Science ®Google Scholar
• Modigliani E, Charbord P, Landman C, . [Myasthenia with monoclonal kappa IgM gammapathy and presence of anti-striated muscle antibodies]. Ann Med Interne (Paris) 1973;124:193–200.
   PubMedGoogle Scholar
• Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007;130:25–35.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005;165:2337–2344.
   PubMed Web of Science ®Google Scholar
• Mackay IR, Rose NR. Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2001;2:793–795.
   PubMed Web of Science ®Google Scholar
• Hansen BA, Sorensen PS, Lauritzen MJ, . A case of malignant lymphoma and myasthenia gravis. Scand J Haematol 1983;31:155–160.
   PubMedGoogle Scholar
• Ehrenfeld M, Abu-Shakra M, Buskila D, . The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 2001;27:750–756.
   PubMed Web of Science ®Google Scholar
• Jardin F, Levesque H, Tilly H. [Auto-immune manifestations in non-Hodgkin's lymphoma]. Rev Med Interne 2005;26:557–571.
   PubMed Web of Science ®Google Scholar
• Varoczy L, Gergely L, Zeher M, . Malignant lymphoma-associated autoimmune diseases—a descriptive epidemiological study. Rheumatol Int 2002;22:233–237.
   PubMed Web of Science ®Google Scholar
• Jonsson V, Wiik A, Hou-Jensen K, . Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. J Intern Med 1999;245:277–286.
   PubMed Web of Science ®Google Scholar
• Jonsson V, Kierkegaard A, Salling S, . Autoimmunity in Waldenstrom's macroglobulinaemia. Leuk Lymphoma 1999;34:373–379.
   PubMed Web of Science ®Google Scholar
• Mihovilovic M, Denning S, Mai Y, . Thymocytes and cultured thymic epithelial cells express transcripts encoding alpha-3, alpha-5, and beta-4 subunits of neuronal nicotinic acetylcholine receptors. Preferential transcription of the alpha-3 and beta-4 genes by immature CD4 + 8 + thymocytes and evidence for response to nicotine in thymocytes. Ann NY Acad Sci 1998;841:388–392.
   PubMed Web of Science ®Google Scholar
• Nelson S, Conti-Tronconi BM. Adult thymus expresses an embryonic nicotinic acetylcholine receptor-like protein. J Neuroimmunol 1990;29:81–92.
   PubMed Web of Science ®Google Scholar
• Hohlfeld R, Wekerle H. The thymus in myasthenia gravis. Neurol Clin 1994;12:331–342.
   PubMed Web of Science ®Google Scholar
• Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475–490.
   PubMed Web of Science ®Google Scholar
• Lefvert AK, Bergstrom K, Matell G, . Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 1978;41:394–403.
   PubMed Web of Science ®Google Scholar
• Eng H, Lefvert AK, Mellstedt H, . Human monoclonal immunoglobulins that bind the human acetylcholine receptor. Eur J Immunol 1987;17:1867–1869.
   PubMed Web of Science ®Google Scholar
• Avrameas S, Ternynck T. The natural autoantibodies system: between hypotheses and facts. Mol Immunol 1993;30:1133–1142.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Shimizu J, . Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182:18–32.
   PubMed Web of Science ®Google Scholar
• Luther C, Adamopoulou E, Stoeckle C, . Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol 2009;183:841–848.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang HB, Chi LJ, . The role of FoxP3 + CD4 + CD25hi Tregs in the pathogenesis of myasthenia gravis. Immunol Lett 2009;122:52–57.
   PubMed Web of Science ®Google Scholar
• Robak T, Blasinska-Morawiec M, Krykowski E, . Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine). Eur J Haematol 1997;58:109–113.
   PubMed Web of Science ®Google Scholar
• Gooptu C, Littlewood TJ, Frith P, . Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001;144:1255–1261.
   PubMed Web of Science ®Google Scholar
• Stern M, Buser AS, Lohri A, . Autoimmunity and malignancy in hematology—more than an association. Crit Rev Oncol Hematol 2007;63:100–110.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Shimoda M, Kawamura M, . Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects. Eur J Neurol 2005;12:566–570.
   PubMed Web of Science ®Google Scholar
• Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005;18:519–525.
   PubMed Web of Science ®Google Scholar
• Lennon VA, Kryzer TJ, Griesmann GE, . Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467–1474.
   PubMed Web of Science ®Google Scholar
• Liesveld JL, Stern A, Rosenthal SN. Myasthenic (Eaton-Lambert) syndrome in association with an indolent non-Hodgkin's lymphoma. NY State J Med 1991;91:29–30.
   PubMedGoogle Scholar
• Tyagi A, Connolly S, Hutchinson M. Lambert-Eaton myaesthenic syndrome: a possible association with Hodgkin's lymphoma. Ir Med J 2001;94:18–19.
   PubMedGoogle Scholar
• O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577–596.
   PubMed Web of Science ®Google Scholar
• Vallat JM, De Mascarel HA, Bordessoule D, . Non-Hodgkin malignant lymphomas and peripheral neuropathies--13 cases. Brain 1995;118:1233–1245.
   PubMed Web of Science ®Google Scholar
• Terenghi F, Ardolino G, Nobile-Orazio E. Guillain-Barre syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma. J Peripher Nerv Syst 2007;12:142–143.
   PubMed Web of Science ®Google Scholar
• Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve 2005;31:301–313.
   PubMed Web of Science ®Google Scholar
• Baehring JM, Damek D, Martin EC, . Neurolymphomatosis. Neuro Oncol 2003;5:104–115.
   PubMed Web of Science ®Google Scholar
• Bennett M, Berrebi A, Katz A. Myasthenia gravis and chronic lymphocytic leukaemia. Eur J Haematol 1989;42:104.
   PubMed Web of Science ®Google Scholar
• Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology 2003;61:1652–1661.
   PubMed Web of Science ®Google Scholar
• Wylam ME, Anderson PM, Kuntz NL, . Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report. J Pediatr 2003;143:674–677.
   PubMed Web of Science ®Google Scholar
• Zaja F, Russo D, Fuga G, . Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology 2000;55:1062–1063.
   PubMed Web of Science ®Google Scholar
• Thakre M, Inshasi J, Marashi M. Rituximab in refractory MuSK antibody myasthenia gravis. J Neurol 2007;254:968–969.
   PubMed Web of Science ®Google Scholar
• Hain B, Jordan K, Deschauer M, . Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab. Muscle Nerve 2006;33:575–580.
   PubMed Web of Science ®Google Scholar
• Baek WS, Bashey A, Sheean GL. Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis. J Neurol Neurosurg Psychiatry 2007;78:771.
   PubMed Web of Science ®Google Scholar
• Zebardast N, Patwa HS, Novella SP, . Rituximab in the management of refractory myasthenia gravis. Muscle Nerve 2010;41:375–378.
   PubMed Web of Science ®Google Scholar
• Nelson RP Jr, Pascuzzi RM, Kessler K, . Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review. J Clin Neuromuscul Dis 2009;10:170–177.
   PubMedGoogle Scholar
• Rey J, Attarian S, Disdier P, . [Myasthenia gravis and chronic lymphocytic leukemia: a lucky association?]. Rev Med Interne 2001;22:1129–1130.
   PubMed Web of Science ®Google Scholar
• Talvalkar GV, Meher-Homji DR. Chronic lymphatic leukaemia associated with myasthenia gravis. Indian J Cancer 1968;5:114–119.
   PubMedGoogle Scholar
• Simpson JA. Myasthenia gravis: a new hypothesis. Scott Med J 1960;5:419–436.
   Google Scholar